These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 16791717)

  • 21. Impact of acarbose on carotid intima-media thickness in patients with newly diagnosed impaired glucose tolerance or mild type 2 diabetes mellitus: A one-year, prospective, randomized, open-label, parallel-group study in Japanese adults with established coronary artery disease.
    Koyasu M; Ishii H; Watarai M; Takemoto K; Inden Y; Takeshita K; Amano T; Yoshikawa D; Matsubara T; Murohara T
    Clin Ther; 2010 Aug; 32(9):1610-7. PubMed ID: 20974318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a nutrition education programme on clinical status and dietary behaviours of adults with type 2 diabetes in a resource-limited setting in South Africa: a randomised controlled trial.
    Muchiri JW; Gericke GJ; Rheeder P
    Public Health Nutr; 2016 Jan; 19(1):142-55. PubMed ID: 25872641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial.
    Suppapitiporn S; Chindavijak B; Onsanit S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S134-41. PubMed ID: 16623018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safe and effective use of medicines for patients with type 2 diabetes - A randomized controlled trial of two interventions delivered by local pharmacies.
    Kjeldsen LJ; Bjerrum L; Dam P; Larsen BO; Rossing C; Søndergaard B; Herborg H
    Res Social Adm Pharm; 2015; 11(1):47-62. PubMed ID: 24798710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effectiveness and safety of liraglutide in clinical practice.
    Ponzani P
    Minerva Endocrinol; 2013 Mar; 38(1):103-12. PubMed ID: 23435446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study.
    Clifford RM; Davis WA; Batty KT; Davis TM;
    Diabetes Care; 2005 Apr; 28(4):771-6. PubMed ID: 15793171
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Hispanic Diabetes Management Program: Impact of community pharmacists on clinical outcomes.
    Oyetayo OO; James C; Martinez A; Roberson K; Talbert RL
    J Am Pharm Assoc (2003); 2011; 51(5):623-6. PubMed ID: 21896461
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a self-management education programme on patients with type 2 diabetes in primary care: A randomised controlled trial.
    Gamboa Moreno E; Mateo-Abad M; Ochoa de Retana García L; Vrotsou K; Del Campo Pena E; Sánchez Perez Á; Martínez Carazo C; Arbonies Ortiz JC; Rúa Portu MÁ; Piñera Elorriaga K; Zenarutzabeitia Pikatza A; Urquiza Bengoa MN; Méndez Sanpedro T; Oses Portu A; Aguirre Sorondo MB; Rotaeche Del Campo R;
    Prim Care Diabetes; 2019 Apr; 13(2):122-133. PubMed ID: 30409669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
    Lalonde L; Quintana-Bárcena P; Lord A; Bell R; Clément V; Daigneault AM; Legris MÈ; Letendre S; Mouchbahani M; Jouini G; Azar J; Martin É; Berbiche D; Beaulieu S; Beaunoyer S; Bertin É; Bouvrette M; Charbonneau-Séguin N; Desrochers JF; Desforges K; Dumoulin-Charette A; Dupuis S; El Bouchikhi M; Forget R; Guay M; Lemieux JP; Morin-Bélanger C; Noël I; Ricard S; Sauvé P; Ste-Marie Paradis F
    Am J Kidney Dis; 2017 Sep; 70(3):386-396. PubMed ID: 28663062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of a Community Pharmacist-Delivered Information Program on the Follow-up of Type-2 Diabetic Patients: A Cluster Randomized Controlled Study.
    Michiels Y; Bugnon O; Chicoye A; Dejager S; Moisan C; Allaert FA; Hunault C; Romengas L; Méchin H; Vergès B
    Adv Ther; 2019 Jun; 36(6):1291-1303. PubMed ID: 31049873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G; Cicero AF; Gaddi AV; Ciccarelli L; Piccinni MN; Salvadeo S; Pricolo F; Fogari E; Ghelfi M; Ferrari I; Fogari R
    Clin Ther; 2005 Sep; 27(9):1383-91. PubMed ID: 16291411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peer-led diabetes education programs in high-risk Mexican Americans improve glycemic control compared with standard approaches: a Project Dulce promotora randomized trial.
    Philis-Tsimikas A; Fortmann A; Lleva-Ocana L; Walker C; Gallo LC
    Diabetes Care; 2011 Sep; 34(9):1926-31. PubMed ID: 21775748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.
    Blonde L; Merilainen M; Karwe V; Raskin P;
    Diabetes Obes Metab; 2009 Jun; 11(6):623-31. PubMed ID: 19515182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of Dader Method for pharmaceutical care on control of blood pressure and total cholesterol in outpatients with cardiovascular disease or cardiovascular risk: EMDADER-CV randomized controlled trial.
    Amariles P; Sabater-Hernández D; García-Jiménez E; Rodríguez-Chamorro MÁ; Prats-Más R; Marín-Magán F; Galán-Ceballos JA; Jiménez-Martín J; Faus MJ
    J Manag Care Pharm; 2012 May; 18(4):311-23. PubMed ID: 22548691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of 1 year of treatment with pioglitazone or rosiglitazone added to glimepiride on lipoprotein (a) and homocysteine concentrations in patients with type 2 diabetes mellitus and metabolic syndrome: a multicenter, randomized, double-blind, controlled clinical trial.
    Derosa G; Cicero AF; D'Angelo A; Gaddi A; Ciccarelli L; Piccinni MN; Salvadeo SA; Pricolo F; Ferrari I; Gravina A; Ragonesi PD
    Clin Ther; 2006 May; 28(5):679-88. PubMed ID: 16861090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain.
    Conthe P; Mata M; Orozco D; Pajuelo F; Barreto CS; Anaya SF; Gomis R
    Diabetes Res Clin Pract; 2011 Jan; 91(1):108-14. PubMed ID: 21035225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
    Bays HE; Goldberg RB; Truitt KE; Jones MR
    Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Short and long-term outcomes from a multisession diabetes education program targeting low-income minority patients: a six-month follow up.
    Ryan JG; Jennings T; Vittoria I; Fedders M
    Clin Ther; 2013 Jan; 35(1):A43-53. PubMed ID: 23328276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.